日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
05/11/2024 | UBS Group AG | 1201(L) | -62,000(L) | HKD3.820(L) | 295,775,721(L) | 9.99 |
01/11/2024 | UBS Group AG | 1104(L) | +1,073,732(L) | 296,837,530(L) | 10.04 | |
30/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +780,000(L) | HKD3.718(L) | 852,828,000(L) | 28.83 |
30/10/2024 | 曲继广 | 1113(L) | +780,000(L) | HKD3.718(L) | 1,139,466,000(L) | 38.52 |
29/10/2024 | 曲继广 | 1113(L) | +1,280,000(L) | HKD3.753(L) | 1,138,686,000(L) | 38.50 |
29/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,280,000(L) | HKD3.753(L) | 852,048,000(L) | 28.81 |
21/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD3.898(L) | 850,768,000(L) | 28.76 |
21/10/2024 | 曲继广 | 1113(L) | +800,000(L) | HKD3.898(L) | 1,137,406,000(L) | 38.45 |
17/10/2024 | UBS Group AG | 1205(L) | -300,000(L) | 295,665,644(L) | 9.99 | |
16/10/2024 | UBS Group AG | 1104(L) | +980,000(L) | 296,385,646(L) | 10.02 | |
14/10/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD4.137(L) | 1,136,606,000(L) | 38.42 |
14/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD4.137(L) | 849,968,000(L) | 28.73 |
08/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD4.358(L) | 848,968,000(L) | 28.70 |
08/10/2024 | 曲继广 | 1113(L) | +800,000(L) | HKD4.358(L) | 1,135,606,000(L) | 38.39 |
04/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +300,000(L) | HKD4.421(L) | 848,168,000(L) | 28.67 |
04/10/2024 | 曲继广 | 1113(L) | +300,000(L) | HKD4.421(L) | 1,134,806,000(L) | 38.36 |
25/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.832(L) | 847,868,000(L) | 28.59 |
25/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.832(L) | 1,134,506,000(L) | 38.26 |
24/09/2024 | 曲继广 | 1101(L) | +1,230,000(L) | HKD3.867(L) | 1,133,506,000(L) | 38.22 |
23/09/2024 | 曲继广 | 1113(L) | +820,000(L) | HKD3.831(L) | 1,132,276,000(L) | 38.18 |
23/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +820,000(L) | HKD3.831(L) | 846,868,000(L) | 28.55 |
11/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,500,000(L) | HKD3.799(L) | 846,048,000(L) | 28.50 |
11/09/2024 | 曲继广 | 1113(L) | +2,500,000(L) | HKD3.799(L) | 1,131,456,000(L) | 38.11 |
10/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.850(L) | 843,548,000(L) | 28.41 |
10/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.850(L) | 1,128,956,000(L) | 38.02 |
09/09/2024 | 曲继广 | 1113(L) | +1,300,000(L) | HKD3.848(L) | 1,127,956,000(L) | 37.99 |
09/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,300,000(L) | HKD3.848(L) | 842,548,000(L) | 28.38 |
05/09/2024 | 曲继广 | 1113(L) | +2,200,000(L) | HKD3.908(L) | 1,126,656,000(L) | 37.94 |
05/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,200,000(L) | HKD3.908(L) | 841,248,000(L) | 28.33 |
04/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.906(L) | 1,124,456,000(L) | 37.87 |
04/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.906(L) | 839,048,000(L) | 28.26 |
03/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.920(L) | 1,123,456,000(L) | 37.84 |
03/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.920(L) | 838,048,000(L) | 28.23 |
02/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,000,000(L) | HKD3.873(L) | 837,048,000(L) | 28.19 |
02/09/2024 | 曲继广 | 1113(L) | +2,000,000(L) | HKD3.873(L) | 1,122,056,000(L) | 37.79 |
02/09/2024 | 曲继广 | 1101(L) | +400,000(L) | HKD3.811(L) | 1,122,456,000(L) | 37.80 |
30/08/2024 | 曲继广 | 1113(L) | +2,350,000(L) | HKD3.890(L) | 1,120,056,000(L) | 37.72 |
30/08/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,350,000(L) | HKD3.890(L) | 835,048,000(L) | 28.12 |
21/08/2024 | 四川科伦药业股份有限公司 | 1101(L) | +5,930,000(L) | HKD3.536(L) | 628,776,000(L) | 21.18 |
18/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD4.675(L) | 832,698,000(L) | 28.05 |
1 2 3 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 12/11/2024 09:33 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |